5 hours Moderna Stock Rises on Q3 Earnings & Sales Beat, Reiterates ViewZacks
MRNA reports better-than-expected third-quarter earnings. It reiterates the guidance of product sales to between $3 billion and $3.5 billion for 2024.
X NYSE Nasdaq 100 Earnings Tech U.S. Science SEC Politics AI Business Energy Dow Jones Wall Street Dividend Investing Markets Crude Oil China Economy S&P 500 Wealth Bitcoin (BTC) World Fed NVIDIA (NVDA) Real Estate Health Tesla (TSLA) Software 3M (MMM) Insurance Gold Money Natural Gas Inflation Canada Entertainment Apple (AAPL) U.K. Options Pharmaceuticals Amazon (AMZN) Boeing (BA) Security Donald Trump Construction Retail Meta Platforms (META) Europe Current Microsoft (MSFT) Hedge Funds Retirement Jim Cramer JPMorgan (JPM) Mining Taxes Manufacturing Google Goldman Sachs (GS) Wells Fargo&Co (WFC) Truist Financial Corp (TFC) Elon Musk Netflix (NFLX) Finance Sports Aerospace Tax Bank of America (BAC) Morgan Stanley (MS) Cars Silver York New York Enterprise Japan Live REITs Airlines Interest Rates Israel Kamala Harris Internet Costco (COST) Economics Space Mortgage Property Milton Florida Texas Warren Buffett IPOs War Boston Intel (INTC) Compound (COMP) BlackRock (BLK) AMD (AMD) ASML (ASML)More +
